ArticleJugan geon-gang gwa jilbyeong2025
[Pilot Project for Early Diagnosis of Malaria Infection Using a Hematology Analyzer].
Article in Jugan geon-gang gwa jilbyeong, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Malaria is a mosquito-borne infectious disease that occurs mainly in areas near the demilitarized zone in the Republic of Korea (ROK). The Korea Disease Control and Prevention Agency is implementing a second Malaria Re-elimination Action Plan (2024-2028) to achieve malaria elimination by 2030. The active and early diagnosis of malaria is essential to achieve this goal. Therefore, a pilot project using hematological analysis was planned and implemented to enable the early detection of malaria in asymptomatic or unsuspected individuals. Methods: A total of 47 medical institutions (including public health centers, hospitals, military hospitals, and commercial reference laboratories) in malaria-risk areas participated in this pilot project. When infected red blood cells (iRBC) were identified through hematological analysis, individuals were classified as suspected cases and referred for confirmatory malaria testing. Monthly data were collected and analyzed to determine the number of iRBC detections, confirmatory tests for malaria, and malaria-positive cases. Results: Between April and October 2024, among 7.27 million hematologic analyses, 1,359 cases of iRBC were detected. Among the 499 cases referred for confirmatory diagnosis, 239 were confirmed as malaria positive. Conclusions: In terms of improving malaria control, it is important to confirm the possibility of an early malaria diagnosis using the existing medical systems without additional budget and human resources. Proactive confirmatory testing for individuals with iRBC, along with the appropriate funding support, can significantly enhance the early detection of infections and serve as an effective strategy for achieving malaria elimination goals in ROK.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.